Fluid Management in Renal Protection

Introduction to Fluid Management

The goal of fluid management in renal protection is to maintain optimal fluid balance and prevent complications, as recommended by the European Society of Cardiology and the American Heart Association 1, 2
The American College of Cardiology suggests that the appropriate use of diuretics is a key element in the success of fluid management, with a high level of evidence 3, 4

The European Society of Cardiology recommends administering furosemide at 0.5-1 mg/kg IV (not exceeding 100 mg in first 6 hours) for clinical evidence of fluid overload or inadequate urine output despite adequate hydration 1
Consider administering furosemide at the end of albumin infusion if used, as suggested by the European Renal Association 5
Furosemide should not be given solely for the purpose of renal protection, according to the American Heart Association, but may be used if there are signs of fluid overload or congestion, as recommended by the European Society of Cardiology 2, 3

The American Heart Association recommends monitoring for electrolyte imbalances (hypokalemia, hyponatremia), hypovolemia and dehydration, and neurohormonal activation when using diuretics, with a strength of evidence based on expert opinion 1
The American College of Cardiology suggests that excessive diuresis leading to hypovolemia can worsen renal perfusion, with a moderate level of evidence 3
Addressing hypokalemia, hyponatremia, or hypomagnesemia that may occur with diuretic therapy is crucial, according to the European Renal Association, with a high level of evidence 5

The Kidney International guideline recommends using 0.9% normal saline as the first-line isotonic crystalloid for most situations 6
Pre-hydration with isotonic fluids is recommended by the Kidney International and European Heart Journal guidelines before administering contrast agents 6, 7
The European Heart Journal guideline recommends using iso-osmolar or low-osmolar contrast agents when IV contrast is required 7
Minimizing contrast volume is recommended by the European Heart Journal guideline to reduce the risk of contrast-induced nephropathy 7
The Kidney International guideline suggests considering oral N-acetylcysteine as adjunctive therapy to reduce the risk of contrast-induced nephropathy 6

Potassium requirement is 1-3 mmol/kg/day in adults, as recommended by the Clinical Nutrition society 8
The following replacement guidelines are recommended:

Providing adequate protein intake of 0.8-1.0 g/kg/day is recommended to prevent protein-energy wasting in patients with kidney disease, according to the Clinical Nutrition guidelines 9
Supplementing water-soluble vitamins, particularly vitamin C, folate, and thiamine, is recommended for patients with kidney disease, as suggested by the Clinical Nutrition guidelines 9
Maintenance fluid requirements in children and infants beyond the neonatal period should be based on weight, as recommended by the Clinical Nutrition society 8
Adults with mild, moderate, or severe volume depletion should receive isotonic fluids orally, nasogastrically, subcutaneously, or intravenously, as recommended by the Clinical Nutrition society 10

Provide written instructions on fluid intake goals, and educate patients on signs of worsening that require immediate medical attention, such as development of confusion or altered mental status, inability to maintain oral intake, severe weakness or cardiac symptoms, seizures, or muscle spasms 11
Arrange for close follow-up, ideally within 24-48 hours, and ensure patient has reliable caregiver support if possible, to ensure timely detection and management of potential complications 11

Discontinuing potentially nephrotoxic medications, such as NSAIDs and aminoglycosides, and minimizing exposure to iodinated contrast is recommended to prevent further kidney damage in patients with kidney disease, as suggested by the American Diabetes Association 12
Regular laboratory monitoring, including creatinine, urea, electrolytes, and acid-base status every 1-3 days initially, is recommended to assess kidney function in patients with kidney disease, as suggested by the American Diabetes Association 12
Monitoring for signs of volume overload, uremic symptoms, or deteriorating kidney function, and watching for complications of CKD, including metabolic bone disease, worsening acidosis, and anemia, is recommended, as suggested by the American Diabetes Association 12
Fluid and electrolyte management should be individualized, considering the type of surgical procedure and important patient factors, including intravascular volume status and acute and chronic comorbidities, as recommended by the British Journal of Anaesthesia 13